[1]孟宪华,陈德道,张樱山,等.藏药“桑蒂”抗肝损伤作用机制研究[J].西部中医药,2014,27(01):135-138.
　MENG Xianhua,CHEN Dedao,ZHANG Yingshan,et al.Study on the Mechanism of Tibetan Medicine "SangDi" Fighting against Liver Damage[J].Western Journal of Traditional Chinese Medicine,2014,27(01):135-138.
点击复制

藏药“桑蒂”抗肝损伤作用机制研究
分享到：

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
27
期数:
2014年01期
页码:
135-138
栏目:
出版日期:
2014-01-14

文章信息/Info

Title:
Study on the Mechanism of Tibetan Medicine "SangDi" Fighting against Liver Damage
文章编号:
1004-6852(2014)01-0135-04
作者:
孟宪华，陈德道，张樱山，刘鸿雁，李智勤，拉毛卓玛
西藏奇正藏药股份有限公司，甘肃 兰州 730000
Author(s):
MENG Xianhua, CHEN Dedao, ZHANG Yingshan, LIU Hongyan, LI Zhiqin, LAMAO Zhuoma
Tibet Cheezheng Tibetan Medicine Co., Ltd, Lanzhou 730000, China
关键词:
肝损伤; 桑蒂; 藏药; 作用机制
Keywords:
liver damage;  SangDi;  Tibetan medicine;  mechanism
分类号:
R282.71
文献标志码:
A
摘要:
从“桑蒂”抗肝损伤作用机制研究现状以及“桑蒂”治疗急性黄疸型肝炎，治疗免疫性肝损伤，治疗急、慢性肝损伤，治疗肝缺血-再灌注损伤(HIRI)的研究文献入手，归纳整理传统藏药“桑蒂”抗肝损伤的作用机制，以期为“桑蒂”的现代化研究提供参考。
Abstract:
The mechanism of Tibetan medicine "SangDi" fighting against liver damage was collected by the literature of current state of mechanism study, "SangDi" in treating acute icteric hepatitis, immunological liver injury, acute, chronic liver damage and hepatic ischemia-reperfusion injury (HIRI), therefore to provide evidence for modern study of "SangDi".

相似文献/References:

[1]黄清杰,李茂星,刘 雄△.中医治疗药物性肝损伤研究进展[J].西部中医药,2012,25(07):124.
　HUANG Qing-jie,LI Mao-xing,LIU Xiong.Progress of Study on Treatment of Drug-induced Liver Injury with TCM[J].Western Journal of Traditional Chinese Medicine,2012,25(01):124.
[2]吕培,何红彦,曹红涛,等.冬虫夏草制剂对抗结核药物致肝肾损伤的“减毒”作用及其机制[J].西部中医药,2020,33(03):16.[doi:10.12174/j.issn.1004-6852.2020.03.05]
　LYU Pei,HE Hongyan,CAO Hongtao,et al.The "Attenuation" Actions and the Mechanism of Dongchong Xiacao Preparation on Liver and Kidney Injury of Antituberculosis Drugs[J].Western Journal of Traditional Chinese Medicine,2020,33(01):16.[doi:10.12174/j.issn.1004-6852.2020.03.05]
[3]李艳,刘丽丽,杨小军,等.慢性乙型肝炎肝郁脾虚证患者中医证候及实验室指标特征观察[J].西部中医药,2022,35(03):72.[doi:10.12174/j.issn.2096-9600.2022.03.17]
　LI Yan,LIU Lili,YANG Xiaojun,et al.Observation on the Characteristics of TCM Syndromes and Lab Indicators of Patients with Chronic Hepatitis B of Liver Depression and Spleen Deficiency Pattern[J].Western Journal of Traditional Chinese Medicine,2022,35(01):72.[doi:10.12174/j.issn.2096-9600.2022.03.17]
[4]吕超,石清兰,覃倩,等.藏、维两族常用保肝药物研究进展[J].西部中医药,2021,34(07):153.[doi:10.12174/j.issn.2096-9600.2021.07.39]
　LYU Chao,SHI Qinglan,QIN Qian,et al.Advances in Research on Common Liver Protective Drugs Used in Tibetan and Uygur[J].Western Journal of Traditional Chinese Medicine,2021,34(01):153.[doi:10.12174/j.issn.2096-9600.2021.07.39]

备注/Memo

备注/Memo:
收稿日期：2013-06-27作者简介：孟宪华(1982—)，男，硕士学位，工程师。研究方向：藏药新药的研究。
更新日期/Last Update: 2014-01-15